Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Tallahassee › NPI 1407031081
Physician

Tallahassee Memorial Healthcare INC

Tallahassee Memorial Healthcare INC was paid $2.24M by Medicaid between Jan 2018 and Dec 2024, across 31 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 63% of everything it billed.

33Billing provider infoTALLAHASSEE MEMORIAL HEALTHCARE INC
TALLAHASSEE, FL 32308
33aNPI1407031081assigned 01/02/2008
28Total paid$2.24M
24GClaims82,301
24DCodes billed31
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Emergency Medicine Physician providers in Florida

Rank by total paid#51 of 391
Median peer was paid$61K
This provider vs. median37×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official PARKS, JENNIFER controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$25K$50K$75K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018116$340.96
201911,471$241K
20208,447$198K
202112,301$363K
202222,371$524K
202318,699$597K
2024incomplete8,896$320K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 63% 27,175 22,124 $1.42M
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 14% 6,270 5,010 $308K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 8.3% 2,853 2,344 $187K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 4.4% 1,340 1,118 $99K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 2.5% 13,745 6,270 $56K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 2.3% 4,358 3,498 $51K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1.1% 7,131 5,887 $25K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 1.1% 421 399 $25K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 593 545 $21K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 700 583 $20K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,120 1,764 $11K
87807 <1% 1,513 1,158 $6K
19 more codes
81025 <1% 3,946 $6K
71046 Radiologic examination, chest; 2 views <1% 875 $5K
81003 <1% 4,753 $3K
86308 <1% 287 $423.33
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 501 $380.03
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 183 $291.26
87210 <1% 145 $166.94
99000 <1% 1,560 $159.77
87490 <1% 126 $110.00
87086 Culture, bacterial; quantitative colony count, urine <1% 390 $61.75
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 273 $51.33
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 46 $41.95
81002 <1% 33 $35.62
82962 <1% 44 $24.83
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 164 $24.00
99072 <1% 605 $16.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 32 $10.57
87070 <1% 41 $4.20
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 0% 78 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPARKS, JENNIFER (PRESIDENT)
Parent organizationTALLAHASSEE MEMORIAL HEALTHCARE INC
Same official

Other billing entities under PARKS, JENNIFER

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.